Ironwood Pharmaceuticals | IRWD - Ebitda

Stock Price
4.55
Daily Change
-0.25 -5.11%
Monthly
-0.98%
Yearly
115.40%
Q1 Forecast
4.74

Ironwood Pharmaceuticals reported $81.81M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Agios Pharmaceuticals USD -125.8M 20.45M Jun/2025
Alnylam Pharmaceuticals USD 381.78M 362.95M Sep/2025
Amarin USD 12.54M 28.57M Jun/2025
Ardelyx USD 5.57M 17.44M Sep/2025
Astellas Pharma JPY 183.68B 31.98B Dec/2025
AstraZeneca USD 4.96B 127M Jun/2025
Charles River Laboratories USD 282.89M 64.81M Sep/2025
Exact Sciences USD 135.42M 2.8M Sep/2025
Halozyme Therapeutics USD 248.25M 22.74M Sep/2025
Incyte USD 581.52M 358.87M Jun/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Moderna USD -208M 552M Sep/2025
Myriad Genetics USD 10.3M 4.2M Sep/2025
Pacira USD 49.36M 4.96M Sep/2025
PTC Therapeutics USD -33.11M 1B Jun/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Takeda JPY 448.13B 173.98B Dec/2025
Ultragenyx Pharmaceutical USD -91.34M 35.09M Jun/2025